Risk of Major Cardiovascular Events in Patients With Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study
J Eur Acad Dermatol Venereol, 2020.
Rungapiromnan W, Mason KJ, Lunt M, McElhone K, Burden AD, Rutter MK, Warren RB, Griffiths CEM, Ashcroft DM; BADBIR Study Group.
Read publication: J Eur Acad Dermatol Venereol
Related
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe pso...
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-b...
0 Comments